{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:42:21Z","timestamp":1780447341500,"version":"3.54.1"},"reference-count":15,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1618,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1111\/j.1365-2230.2011.04031.x","type":"journal-article","created":{"date-parts":[[2011,3,28]],"date-time":"2011-03-28T16:27:12Z","timestamp":1301329632000},"page":"4-11","source":"Crossref","is-referenced-by-count":8,"special_numbering":"supplement s2","title":["Influence of alitretinoin on the pharmacokinetics of the oral contraceptive ethinyl estradiol\/norgestimate"],"prefix":"10.1093","volume":"36","author":[{"given":"A. H.","family":"Schmitt-Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schleimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Schoetzau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. T.","family":"Leese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Weidekamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Maares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,3,28]]},"reference":[{"key":"10.1111\/j.1365-2230.2011.04031.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1365-2133.2008.08487.x","article-title":"Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial","volume":"158","author":"Ruzicka","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2011.04031.x-BIB2|cit2","first-page":"1","article-title":"Epidemiology of hand eczema in an industrial city","volume":"153","author":"Meding","year":"1990","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"issue":"Suppl. 49","key":"10.1111\/j.1365-2230.2011.04031.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2133.1996.tb15661.x","article-title":"Oral retinoids - efficacy and toxicity in psoriasis","volume":"135","author":"Gollnick","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2011.04031.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/j.1552-4604.1997.tb04338.x","article-title":"Pharmacokinetics and pharmacodynamics of 9-cis-retinoic acid in healthy men","volume":"37","author":"Weber","year":"1997","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/j.1365-2230.2011.04031.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0009-9236(99)70138-4","article-title":"The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive","volume":"65","author":"Barditch-Crovo","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1365-2230.2011.04031.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/009127009803801109","article-title":"Effects of rifabutin and rifampicin on the pharmacokinetics of ethinylestradiol and norethindrone","volume":"38","author":"LeBel","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/j.1365-2230.2011.04031.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/j.1552-4604.1998.tb04472.x","article-title":"Effects of ABT-761, a novel 5-lipoxygenase inhibitor, on the pharmacokinetics of a single dose of ethinyl estradiol and levonorgestrel in healthy female volunteers","volume":"38","author":"Wong","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/j.1365-2230.2011.04031.x-BIB8|cit8","doi-asserted-by":"crossref","DOI":"10.1201\/b14095","volume-title":"Pharmacokinetics","author":"Gibaldi","year":"1982"},{"key":"10.1111\/j.1365-2230.2011.04031.x-BIB9|cit9","first-page":"265","article-title":"Clinical chemical methods for the routine assessment of the vitamin status in human populations. Part I. The fat-soluble vitamins A and E, and beta-carotene","volume":"53","author":"Vuilleumier","year":"1983","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1111\/j.1365-2230.2011.04031.x-BIB10|cit10","volume-title":"Guidance for Industry: In-Vivo Drug Metabolism\/Drug Interaction Studies: Study Design, Data Analysis, and Recommendations for Dosing and Labeling","author":"U.S. Department of Health and Human Services","year":"1999"},{"key":"10.1111\/j.1365-2230.2011.04031.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2165\/00003495-198734040-00003","article-title":"The retinoids. A review of their clinical pharmacology and therapeutic use","volume":"34","author":"Orfanos","year":"1987","journal-title":"Drugs"},{"key":"10.1111\/j.1365-2230.2011.04031.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2165\/00003495-199753030-00003","article-title":"Current use and future potential role of retinoids in dermatology","volume":"53","author":"Orfanos","year":"1997","journal-title":"Drugs"},{"key":"10.1111\/j.1365-2230.2011.04031.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/0002-9378(90)90552-I","article-title":"Pharmacologic and pharmacokinetic characteristics of norgestimate and its metabolites","volume":"163","author":"McGuire","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1365-2230.2011.04031.x-BIB14|cit14","volume-title":"Physicians\u2019 Desk Reference","year":"2001"},{"key":"10.1111\/j.1365-2230.2011.04031.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0015-0282(03)00556-9","article-title":"Ortho Evra\/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error","volume":"80","author":"Pierson","year":"2003","journal-title":"Fertil Steril"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2230.2011.04031.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2230.2011.04031.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:09:09Z","timestamp":1676365749000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/36\/s2\/4\/6622382"}},"subtitle":["Influence of alitretinoin on the PK of oral contraceptives"],"short-title":[],"issued":{"date-parts":[[2011,3,28]]},"references-count":15,"URL":"https:\/\/doi.org\/10.1111\/j.1365-2230.2011.04031.x","relation":{},"ISSN":["0307-6938"],"issn-type":[{"value":"0307-6938","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3,28]]}}}